Enduring Material

Journal Club presents “Systemic Treatment Effects on Comorbidities of Psoriasis”
View Activity Info
Enter Basic User Info
View Content
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
 
 
National Psoriasis Foundation

6600 SW 92nd Ave., Suite 300
Portland, OR 97223-7195
General Information
Wednesday, February 10, 2021 - Thursday, February 10, 2022
National Psoriasis Foundation
Virtual Conference Room
Psound Bytes CME Podcast
National Psoriasis Foundation
Objectives
  • Increased understanding of how psoriatic disease can affect the feet
  • Understand the effects of systemic psoriasis treatment on CVD, diabetes, and psoriatic arthritis
Presentations and Speakers
Journal Club presents “Systemic Treatment Effects on Comorbidities of Psoriasis”
  • Mark Lebwohl, MD - Icahn School of Medicine at Mount Sinai, Professor and Chairman Department of Dermatology
  • Nehal Mehta, MD
  • Heather Teague, MD
Available Credits/Points
  • The National Psoriasis Foundation designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hear dermatologist Dr. Mark Lebwohl, Mt Sinai Health System, cardiologist and Chief of the Section of Inflammation and Cardiometabolic Diseases at the National Institutes of Health in Bethesda, Dr. Nehal Mehta, and Dr. Heather Teague, also from the NIH Section of Inflammation & Cardiometabolic Diseases discuss the effect of systemic psoriasis treatments on CVD, diabetes, and psoriatic arthritis. This program is supported by educational grants from AbbVie, Amgen, Janssen and UCB.
Disclosure Statements
NPF Staff/Planning Committee, has disclosed no relevant financial relationships with commercial interests.
Speakers:
Mark Lebwohl, MD has disclosed a relevant financial relationship with a commercial interest in the last 12 months:
  • Allergan, Almirall, Arcuitis, Avotres Therapeutics, Birch BioMed Inc, BMD Skincare, Boehringer-Ingelham, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Corrona, Dermavant Science, EMD Seroko, Evelo Biosciences Foundation - Consulting
  • Abbvie, Amgen, Arcutis, AstraZeneca, Boehringer Ingelheim, Celgene, Elli Lilly, Incyte, Janssen Research & Development, Kadmon Corp, Leo Pharmaceutical, Medimmune, Novartis, Ortho Dematologics, Pfizer, Sciderm, UCB & Vida - Grants


Heather Teague, MD has no financial relationships to report in the last 24 months with an ineligible company.

Accreditation Statement
  • The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Test Information
100 %
2/10/2021
Continue to Enduring Material